Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
Stanley Cohan1,2,3 1Providence Multiple Sclerosis Center, 2Providence Brain and Spine Institute, 3Providence Health & Services, Portland, OR, USA Abstract: Despite the availability of multiple disease-modifying therapies for relapsing multiple sclerosis (MS), there remains a need for highly...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-09-01
|
| Series: | Biologics : Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/therapeutic-efficacy-of-monthly-subcutaneous-injection-of-daclizumab-i-peer-reviewed-article-BTT |